Enteroviruses

Principles and Practice of Clinical Virology: Sixth Edition

Volumn , Issue , 2009, Pages 601-624

  Minor, Philip D ^a   Muir, Peter ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antigenic structure of virus; Bornholm disease (epidemic pleurodynia); Cellular receptor sites; Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME); Enterovirus diversity and classification; Enterovirus virion; Enteroviruses belonging to Picornaviridae; Myocarditis and ortho and paramyoxoviruses, togaviruses; Pathobiological and clinical aspects of human enteroviruses

Indexed keywords

EID: 84856288393     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470741405.ch25     Document Type: Chapter

References (97)

1. Abzug, J.M., Keyserling, H.L., Lee, M.L. et al. (1995) Neonatal enterovirus infection: virology, serology and effects of intravenous immune globulin. Clinical Infectious Diseases, 20, 1201.
2. Adu, F., Iber, J., Bukbuk, D. et al. (2007) Isolation of recombinant type 2 vaccine derived poliovirus (VDPV) from a Nigerian child. Virus Research, 127, 17.
3. Alexander, J.P., Baden, L., Pallansch, M.A. et al. (1994) Enterovirus 71 infections and neurological disease. United States 1987-1991. The Journal of Infectious Diseases, 169, 905.
4. Archard, L.C., Bowles, N.E., Behan, P.O. et al. (1988) Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatinine kinase. Journal of the Royal Society of Medicine, 81, 326.
5. Archard, L.C., Khan, M.A., Soteriou, B.A. et al. (1998) Characterisation of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse-transcription-nested polymerase chain reaction products. Human Pathology, 29, 578.
6. Banatvala, J.E., Schernthaner, G., Schober, E. et al. (1985) Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin- dependent diabetes mellitus in Britain, Austria and Australia. Lancet, i, 1049.
7. Behan, P.O., Behan, W.M.H. and Bell, E.J. (1985) The postviral fatigue syndrome: an analysis of the findings in 50 cases. The Journal of Infection, 10, 211.
8. Bell, E.J., McCartney, R.A. and Banatvala, J.E. (1986) The routine use of μ-antibody capture ELISA for the serological diagnosis of Coxsackie B virus infections. Journal of Medical Virology, 19, 205.
9. Bergelson, J.M., Shepley, M.P., Chan, B.M.C. et al. (1992) Identification of the integrin VLA-2 as a receptor for ECV 1. Science, 255, 1718.
10. Bergelson, J.M., Chan, M., Solomon, K. et al. (1994) Decay-accelerating factor (CD55), a glycosylphosphotidylinositol- anchored complement regulation protein, is a receptor for many ECVes. Proceedings of the National Academy of Sciences of the United States of America, 91, 6245.
11. Bergelson, J.M., Cunningham, J.A., Droguett, G. et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 275, 1320.
12. Bowles, N.E., Richardson, P.J., Olsen, E.G. et al. (1986) Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet, i, 1120.
13. Bowles, N.E., Dubowitz, V., Sewry, C.A. et al. (1987) Dermatomyositis, polymyositis and Coxsackie-B-virus infection. Lancet, i, 1004.
14. Burns, C.C., Shaw, J., Campagnoli, R. et al. (2006) Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. Journal of Virology, 80, 3259.
15. Cambridge, G., MacArthur, C.G.C., Waterson, A.P. et al. (1979) Antibodies to Coxsackie B viruses in primary congestive cardiomyopathy. British Heart Journal, 41, 692.
16. Centers for Disease Control and Prevention (2003) Progress toward global eradication of poliomyelitis, 2002. Morbidity and Mortality Weekly Report 52, 366-69.
17. Chang, L.Y., Lin, T.Y., Hsu, K.H. et al. (1999) Clinical features and risk factors of pulmonary oedema after enterovirus-71- related hand, foot, and mouth disease. Lancet, 354, 1682.
18. Clements, G.B., Galbraith, D.N. and Taylor, K.W. (1995a) Coxsackie B virus infection and onset of childhood diabetes. Lancet, 346, 221.
19. Clements, G.B., McGarry, F., Nairn, C. et al. (1995b) The detection of enterovirus specific RNA in serum: the relationship to chronic fatigue. Journal of Medical Virology, 45, 151.
20. Coyne, C.B. and Bergelson, J.M. (2006) Virus-induced Abl and Fyn kinase signals permit Coxsackievirus entry through epithelial tight junctions. Cell, 124, 119.
21. Dalldorf, G. and Sickles, G.M. (1948) An unidentified filtrable agent isolated from the faeces of children with paralysis. Science, 108, 61.
22. da Silva, E.E., Winkler, M.T. and Pallansch, M.A. (1996) Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerging Infectious Diseases, 2, 231.
23. Dowdle, W., van der Voort, H., de Gourville, E. et al. (2006) Containment of poliovirus after eradication and OPV cessation: characterizing risks to improve management. Risk Analysis, 26, 1449.
24. Enders, J.F., Weller, T.H. and Robbins, F.C. (1949) Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science, 109, 85.
25. Galbraith, D.N., Nairn, C. and Clements, G.B. (1995) Phylogenetic analysis of short enteroviral sequences from patient with chronic fatigue syndrome. The Journal of General Virology, 76, 1701.
26. Giraud, P., Beaulieux, F., Ono, S. et al. (2001) Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients. Neurology, 56, 1777.
27. Halsey, N.A., Pinto, J., Espinosa-Rosales, F. et al. (2004) Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil and the United Kingdom. Bulletin of the World Health Organization, 82, 3.
28. Heim, A., Stille-Siegener, M., Kandolf, R. et al. (1994) Enterovirus-induced myocarditis: hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-a. Clinical Cardiology, 17, 563.
29. Hellen, C.U., Witherell, G.W., Schmid, M. et al. (1993) A cytoplasmic 57kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proceedings of the National Academy of Sciences of the United States of America, 90, 7642.
30. Hiltunen, M., Hyöty, H., Knip, M. et al. (1997) Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. The Journal of Infectious Diseases, 175, 554.
31. Ho, M., Chen, E.R., Hsu, K.H. et al. (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. The New England Journal of Medicine, 341, 929.
32. Hogle, J.M., Chow, M. and Filman, D.J. (1985) The three dimensional structure of poliovirus at 2.9 °A resolution. Science, 229, 1358.
33. Horwitz, M.S., Bradley, L.M. and Harbertson, J. (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Medicine, 4, 781.
34. Horwitz, M.S., La Cava, A., Fine, C. et al. (2000) Pancreatic expression of interferon-gamma protects mice from lethal Coxsackie virus B3 infection and subsequent myocarditis. Nature Medicine, 6, 693.
35. Hyöty, H., Hiltunen, M., Knip, M. et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes, 44, 652.
36. Hyypiä, T., Hovi, T., Knowles, N.J. et al. (1997) Classification of enteroviruses based on molecular and biological properties. The Journal of General Virology, 78, 1.
37. Ida-Hosonuma, M., Iwasaki, T., Yoshiwaka, T. et al. (2005) The alpha/beta interferon response controls tissue tropism and pathogenesis of poliovirus. Journal of Virology, 79, 4460.
38. Kammerer, U., Kunkel, B. and Korn, K. (1994) Nested polymerase chain reaction for specific detection and rapid identification of human picornaviruses. Journal of Clinical Microbiology, 32, 285.
39. Kandolf, R., Canu, A., Klingel, K. et al. (1990) Molecular studies on enteroviral heart disease, in New Aspects of Positive Strand RNA Viruses (eds M.A. Brinton and F.X. Heinz), American Society for Microbiology, Washington, DC, pp. 340-48.
40. Karnauchow, T.M., Tolson, D.L., Harrison, B.A. et al. (1996) The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). Journal of Virology, 70, 5143.
41. Kew, O.M., Sutter, R.W., de Gourville, E.M. et al. (2005) Vaccine derived polioviruss and the endgame strategy for polio eradication. Annual Review of Microbiology, 59, 5887.
42. Kilpatrick, D.R., Nottay, B., Yang, C.-F. et al. (1996) Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. Journal of Clinical Microbiology, 34, 2990.
43. King, M.L., Shaikh, A., Bidwell, D. et al. (1983) Coxsackie-B-virus-specific IgM response in children with insulin dependent (juvenile-onset, type I) diabetes mellitus. Lancet, i, 1397.
44. Koike, S., Taya, C., Kurata, T. et al. (1991) Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences of the United States of America, 88, 951.
45. Leff, R.L., Love, L.A., Miller, F.W. et al. (1992) Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet, 339, 1192.
46. Leparc-Goffart, I., Julien, J., Fuchs, F. et al. (1996) Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. Journal of Clinical Microbiology, 34, 2023.
47. Lindh, G., Samuelson, A., Hedlund, K.O. et al. (1996) No findings of enteroviruses in Swedish patients with chronic fatigue syndrome. Scandinavian Journal of Infectious Diseases, 28, 305.
48. Liu, P.P. and Mason, J.W. (2001) Advances in the understanding of myocarditis. Circulation, 104, 1076.
49. Macadam, A.J., Ferguson, G., Stone, D.M. et al. (2006) Rational design of genetically stable, live attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. Journal of Virology, 80, 8653.
50. MacLennan, C. and MacLennan, J. (2005) What threat from persistent vaccine related poliovirus? Lancet, 366, 351.
51. MacLennan, C., Dunn, G., Huisson, A.P. et al. (2004) Failure to clear persistent vaccine derived neurovirulent poliovirus infection in an immunodeficient man. Lancet, 363, 1509.
52. Magrath, D.I., Evans, D.M.A., Ferguson, M. et al. (1986) Antigenic properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. The Journal of General Virology, 67, 899.
53. Malnou, C.E., Pöyry, T., Jackson, R.J. and Kean, K.M. (2002) Poliovirus internal ribosome entry segment structure alterations that specifically affect function in neuronal cells: molecular genetic analysis. Journal of Virology, 76, 10617.
54. Martin, A.B., Webber, S., Fricker, F.J. et al. (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation, 90, 330.
55. Mason, J.W., O'Connell, J.B., Herskowitz, S. et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. The New England Journal of Medicine, 333, 269.
56. Mawle, A.C., Nisenboum, R., Dobbins, J.-G. et al. (1995) Seroepidemiology of chronic fatigue syndrome: a case control study. Clinical Infectious Diseases, 21, 1386.
57. McArdle, A., McArdle, F., Jackson, M.J. et al. (1996) Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clinical Science, 90, 295.
58. Mendelsohn, C., Wimmer, E. and Racaniello, V.R. (1989) Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell, 56, 855.
59. Minor, P.D. (1990) Antigenic structure of picornaviruses. Current Topics in Microbiology and Immunology, 161, 122.
60. Minor, P.D. (1996) Poliovirus, in Viral Pathogenesis (eds N. Nathanson, R. Ahmed, F. Gonzalez-Scarano et al.), Lippincott-Raven, Philadelphia, PA, pp. 555-74.
61. Minor, P.D., Pipkin, P.A., Hockley, D. et al. (1984) Monoclonal antibodies which block cellular receptors of poliovirus. Virus Research, 1, 203.
62. Minor, P., Brown, F., Domingo, E. et al. (1995) Picornaviridae, in Virus Taxonomy. Classification and Nomenclature of Viruses. Sixth Report of the International Committee on Taxonomy of Viruses Virology Division (eds F.A. Murphy, C.M. Fauquet, D.H.L. Bishop et al.), International Union of Microbiological Societies/ Academic Press, London.
63. Modlin, J.F. (1988) ECV infections of newborn infants. The Pediatric Infectious Disease Journal, 7, 311.
64. Modlin, J.F., Dagan, R., Berlin, L.E. et al. (1991) Focal encephalitis with enterovirus infections. Pediatrics, 88, 841.
65. Muir, P. and Archard, L.C. (1994) There is evidence for persistent enterovirus infections in chronic medical conditions in humans. Reviews in Medical Virology, 4, 245.
66. Muir, P. and Banatvala, J.E. (1990) Reactivity of enterovirus-specific IgM with infective and defective Coxsackie B virions in patients with monotypic and multitypic IgM responses. Journal of Virological Methods, 29, 209.
67. Muir, P., Nicholson, F., Tilzey, A.J. et al. (1989) Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet, i, 804.
68. Muir, P., Nicholson, F., Spencer, G.T. et al. (1996) Enterovirus infection of the central nervous system of humans; lack of association with chronic neurological disease. The Journal of General Virology, 77, 1469.
69. Munsat, T.L. (1991) Poliomyelitis: new problems with an old disease. The New England Journal of Medicine, 324, 1206.
70. Nathanson, N. and Langmuir, A.D. (1963) The Cutter incident: poliomyelitis following formaldehyde inactivated poliovirus vaccination in the United States during the spring of 1955. American Journal of Hygiene, 78, 16.
71. Nicholson, F., Ajetunmobi, J.F., Li, M. et al. (1995) Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis. British Heart Journal, 74, 522.
72. Nkowane, B.M., Wassilak, S.G., Oversteen, W.A. et al. (1987) Vaccine associated paralytic poliomyelitis in the United States: 1973-1984. Journal of the American Medical Association, 257, 1335.
73. Oberste, M.S., Kaija Maher, K., Kilpatrick, D.R. et al. (1999) Typing of human enteroviruses by partial sequencing of VP1. Journal of Clinical Microbiology, 37, 1288.
74. Pallansch, M.A. and Roos, R.P. (2001) Enteroviruses: polioviruses, Coxsackie viruses, ECVes, and newer enteroviruses, in Fields Virology, 4th edn (eds D.M. Knipe, P.M. Howley, D.E. Griffin and R.A. Lamb), Lippincott-Raven, Philadelphia, PA, p. 723.
75. Pelletier, J. and Sonnenberg, N. (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature, 334, 320.
76. Pöyry, T., Kinnunen, L., Hyypiä, T. et al. (1996) Genetic and phylogenetic clustering of enteroviruses. The Journal of General Virology, 77, 1699.
77. Reetoo, K.N., Osman, S.A., Illavia, S.J. et al. (2000) Quantitative analysis of viral RNA kinetics in Coxsackie virus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. The Journal of General Virology, 81, 2755.
78. Ren, R., Costantini, F.C., Gorgaez, E.J. et al. (1990) Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell, 63, 353.
79. Romero, J.R. (2001) Pleconaril: a novel antipicornaviral drug. Expert Opinion on Investigational Drugs, 10, 369.
80. Rotbart, H.A. (1990) Enzymatic RNA amplification of the enteroviruses. Journal of Clinical Microbiology, 28, 438.
81. Rotbart, H.A. (1995) Enteroviral infections of the central nervous system. Clinical Infectious Diseases, 20, 971.
82. Rueckert, R.R. and Wimmer, E. (1984) Systematic nomenclature of picornavirus proteins. Journal of Virology, 50, 957.
83. Sabin, A.B. (1982) Vaccine control of poliomyelitis in the 1980s. Journal of Biology and Medicine, 55, 383.
84. Salminen, K., Sadeharju, K., Lonnröt, M. et al. (2003) Enterovirus infections are associated with the induction of ß-cell autoimmunity in a prospective birth cohort study. Journal of Medical Virology, 69, 91.
85. Schlesinger, Y., Sawyer, M.H. and Storch, G.A. (1994) Enteroviral meningitis in infancy: potential for polymerase chain reaction in patient management. Pediatrics, 94, 157.
86. Schwaiger, A., Umlauft, F., Weyrer, K. et al. (1993) Detection of enterovirus ribonucleic acid in myocardialbiopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. American Heart Journal, 126, 406.
87. Shafren, D.R., Bates, R.C., Agrez, M.V. et al. (1995) Coxsackie virus Bl, B3, and B5 use decay-accelerating factor as a receptor for cell attachment. Journal of Virology, 69, 3873.
88. Shimizu, H., Thorley, B., Paladin, F.J. et al. (2004) Circulation of type 1 vaccine derived poliovirus in the Phillipines in 2001. Journal of Virology, 78, 13512.
89. Stanway, G. (1990) Structure, function and evolution of picornaviruses. The Journal of General Virology, 71, 2483.
90. Straus, S.E. (1996) Chronic fatigue syndrome. British Medical Journal, 313, 831.
91. Trabelsi, A., Grattard, F., Nejmeddine, M. et al. (1995) Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/l, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture. Journal of Clinical Microbiology, 33, 2454.
92. Uhlig, J., Wiegers, K. and Demick, R. (1990) A new antigenic site of poliovirus recognised by an intertypic cross-neutralizing monoclonal antibody. Virology, 178, 606.
93. Vinje, J., Gregoricus, N., Martin, J. et al. (2004) Isolation and characterization of circulating type 1 vaccine derived poliovirus from sewage and stream waters in Hispaniola. The Journal of Infectious Diseases, 189, 1168.
94. Wilfert, C.M., Buckley, R.H., Mohanakumar, T. et al. (1977) Persistent and fatal central nervous system ECV infections in agammaglobulinaemia. The New England Journal of Medicine, 296, 1485.
95. Woodall, C.J., Riding, M.H., Graham, D.I. et al. (1994) Sequences specific for enteroviruses detected in spinal cord from patients with motor neurone disease. British Medical Journal, 308, 1541.
96. Yang, C.F., De, L., Holloway, B.P. et al. (1991) Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Research, 20, 159.
97. Yousef, G.E., Bell, E.J., Mann, G.F. et al. (1988) Chronic enterovirus infection in patients with post-viral fatigue syndrome. Lancet, 1, 146.